{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:14:32Z","timestamp":1778577272214,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-03667"],"award-info":[{"award-number":["2016-03667"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-03317"],"award-info":[{"award-number":["2020-03317"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017699","name":"Galecto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["KAW 2013.0022"],"award-info":[{"award-number":["KAW 2013.0022"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005753","name":"Royal Physiographic Society of Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bmc.2024.117989","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:12:11Z","timestamp":1730981531000},"page":"117989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Sulfonamide-derivatized galactosides selectively target an unexplored binding site in the galectin-9N-terminal domain"],"prefix":"10.1016","volume":"116","author":[{"given":"Mukul","family":"Mahanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofi","family":"Gummesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Sundin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakon","family":"Leffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf J","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117989_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jcs.208884","article-title":"Galectins at a glance","volume":"131","author":"Johannes","year":"2018","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bmc.2024.117989_b0010","first-page":"1","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"415","author":"Wolf","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmc.2024.117989_b0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41423-023-01074-1","article-title":"Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection","volume":"20","author":"Pinho","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.bmc.2024.117989_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105400","article-title":"The universe of galectin-binding partners and their functions in health and disease","volume":"299","author":"Troncoso","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmc.2024.117989_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2019.00823","article-title":"The structural biology of galectin-ligand recognition: current advances in modeling tools, protein engineering, and inhibitor design","volume":"7","author":"Modenutti","year":"2019","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.tips.2023.06.001","article-title":"Targeting galectin-3 in inflammatory and fibrotic diseases","volume":"44","author":"Bouffette","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2024.117989_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104287","article-title":"Galectin-9 as a biomarker of disease severity","volume":"361","author":"Moar","year":"2021","journal-title":"Cell Immunol"},{"key":"10.1016\/j.bmc.2024.117989_b0045","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2024.117989_b0050","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nm.4314","article-title":"Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance","volume":"23","author":"Daley","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2024.117989_b0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2217\/imt-2021-0075","article-title":"Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bmc.2024.117989_b0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2021.1903430","article-title":"An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016-present)","volume":"31","author":"Sethi","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2024.117989_b0065","doi-asserted-by":"crossref","first-page":"16980","DOI":"10.1021\/acs.jmedchem.3c01787","article-title":"Discovery of selective and orally available galectin-1 inhibitors","volume":"66","author":"Zetterberg","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0070","doi-asserted-by":"crossref","first-page":"12626","DOI":"10.1021\/acs.jmedchem.2c00660","article-title":"Discovery and optimization of the first highly effective and orally available galectin-3 inhibitors for treatment of fibrotic disease","volume":"65","author":"Zetterberg","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0075","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1021\/acs.jmedchem.7b01626","article-title":"Systematic tuning of fluoro-galectin-3 interactions provides thiodigalactoside derivatives with single-digit nM affinity and high selectivity","volume":"61","author":"Peterson","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/cmdc.201700744","article-title":"Monosaccharide derivatives with low-nanomolar lectin affinity and high selectivity based on combined fluorine-amide, phenyl-arginine, sulfur-\u03c0, and halogen bond interactions","volume":"27","author":"Zetterberg","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2024.117989_b0085","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/cbic.201600285","article-title":"Galectin-3-binding glycomimetics that strongly reduce bleomycin-induced lung fibrosis and modulate intracellular glycan recognition","volume":"17","author":"Delaine","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmc.2024.117989_b0090","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1016\/j.bmc.2010.05.040","article-title":"1H\u20131,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors","volume":"18","author":"Salameh","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0095","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1016\/j.bmcl.2005.05.084","article-title":"3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3","volume":"15","author":"Salameh","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117989_b0100","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1021\/acs.jmedchem.4c00485","article-title":"Discovery of the selective and orally available galectin-1 inhibitor GB1908 as a potential treatment for lung cancer","volume":"67","author":"Zetterberg","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions","volume":"13","author":"Ovung","year":"2021","journal-title":"Biophys Rev"},{"key":"10.1016\/j.bmc.2024.117989_b0110","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1021\/ja103081n","article-title":"Investigation of the mechanism of C(sp3)\u2212H bond cleavage in Pd(0)-catalyzed intramolecular alkane arylation adjacent to amides and sulfonamides","volume":"132","author":"Rousseaux","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2024.117989_b0115","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1021\/acs.cgd.0c01469","article-title":"Effect of halogen bonding on chiral assemblies of achiral sulfonamide molecules in the crystalline phase","volume":"21","author":"Kikkawa","year":"2020","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.bmc.2024.117989_b0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0008-6215(94)84275-2","article-title":"Recognition of synthetic O-methyl, epimeric, and amino analogues of the acceptor alpha-L-Fuc p-(1\u2013>2)-beta-D-Gal p-OR by the blood-group A and B gene-specified glycosyltransferases","volume":"251","author":"Lowary","year":"1994","journal-title":"Carbohyd Res"},{"key":"10.1016\/j.bmc.2024.117989_b0125","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1016\/S0021-9258(18)67499-X","article-title":"Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides","volume":"261","author":"Leffler","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0130","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1021\/acs.joc.5b00274","article-title":"One-pot sonogashira coupling-cyclization toward regioselective synthesis of benzosultams","volume":"80","author":"Debnath","year":"2015","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0135","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0076-6879(03)01033-4","article-title":"Fluorescence polarization to study galectin-ligand interactions","volume":"362","author":"Sorme","year":"2003","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bmc.2024.117989_b0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ab.2004.06.042","article-title":"Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions","volume":"334","author":"Sorme","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2024.117989_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109636","article-title":"Interplay of halogen bonding and solvation in protein\u2013ligand binding","volume":"27","author":"Verteramo","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bmc.2024.117989_b0150","doi-asserted-by":"crossref","first-page":"14716","DOI":"10.1021\/acs.jmedchem.3c01223","article-title":"Ligand sulfur oxidation state progressively alters galectin-3-ligand complex conformations to induce affinity-influencing hydrogen bonds","volume":"66","author":"Mahanti","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117989_b0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/jacsau.0c00094","article-title":"Entropy-entropy compensation between the protein, ligand, and solvent degrees of freedom fine-tunes affinity in ligand binding to galectin-3C","volume":"1","author":"Wallerstein","year":"2021","journal-title":"JACS Au"},{"key":"10.1016\/j.bmc.2024.117989_b0160","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/jacs.8b11099","article-title":"Interplay between conformational entropy and solvation entropy in protein-ligand binding","volume":"141","author":"Verteramo","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2024.117989_b0165","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1002\/chem.201003247","article-title":"Arene-anion based arginine-binding motif on a galactose scaffold: structure-activity relationships of interactions with arginine-rich galectins","volume":"17","author":"Oberg","year":"2011","journal-title":"Chemistry"},{"key":"10.1016\/j.bmc.2024.117989_b0170","doi-asserted-by":"crossref","first-page":"14577","DOI":"10.1021\/ja105852y","article-title":"Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3","volume":"132","author":"Diehl","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2024.117989_b0175","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/ja043475p","article-title":"Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction","volume":"127","author":"Sorme","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2024.117989_b0180","article-title":"Determining the affinity and kinetics of small molecule inhibitors of galectin-1 using surface plasmon resonance","volume":"25","author":"Kim","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117989_b0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.slasd.2023.03.005","article-title":"Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonance","author":"Kim","year":"2023","journal-title":"SLAS Discov"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:32:22Z","timestamp":1778574742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624004036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"alternative-id":["S0968089624004036"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117989","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfonamide-derivatized galactosides selectively target an unexplored binding site in the galectin-9N-terminal domain","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117989"}}